Increased prevalence of inhibitors in Hispanic patients with severe haemophilia A enrolled in the Universal Data Collection database

Haemophilia

Volumn 18, Issue 3, 2012, Pages

  Carpenter, Shannon L ^a   Michael Soucie, J ^b   Sterner, S ^c   Presley, R ^b  

^a Children's Mercy Hospital   (Canada)

^b NATIONAL CENTER ON BIRTH DEFECTS AND DEVELOPMENTAL DISABILITIES   (United States)

^c Mays Cancer Center at UT Health San Antonio   (United States)

Author keywords

Ethnicity; Factor VIII; Haemophilia A; Hispanic; Inhibitors; UDC

Indexed keywords

BLOOD CLOTTING FACTOR 8 INHIBITOR;

ADOLESCENT; ADULT; ARTICLE; CHILD; CONTROLLED STUDY; DISEASE SEVERITY; ETHNICITY; HEMOPHILIA A; HISPANIC; HLA SYSTEM; HUMAN; MAJOR CLINICAL STUDY; MALE; PERSONALIZED MEDICINE; PRESCHOOL CHILD; PREVALENCE; PRIORITY JOURNAL; RACE DIFFERENCE; SCHOOL CHILD;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; FACTOR VIII; HEMOPHILIA A; HISPANIC AMERICANS; HUMANS; INFANT; ISOANTIBODIES; LOGISTIC MODELS; MALE; UNITED STATES; YOUNG ADULT;

EID: 84860351786     PISSN: 13518216     EISSN: 13652516     Source Type: Journal    
DOI: 10.1111/j.1365-2516.2011.02739.x     Document Type: Article

References (29)

1. Goudemand J, Laurian Y, Calvez T. Risk of inhibitors in haemophilia and the type of factor replacement. Current Opinion Hemat 2006; 13: 316-22.
2. Oldenburg J, Schroder J, Brackmann HH, Muller-Reible C, Schwaab R, Tuddenham E. Environmental and genetic factors influencing inhibitor development. Semin Hemat 2004; 41: 82-8.
3. Oldenburg J, Brackmann H, Schwabb R. Risk factors for inhibitor development in hemophilia A. Haematologica 2000; 85: 7-14.
4. Ananyeva N, Lacroix-Desmazes S, Hauser CA et al. Inhibitors in hemophilia A: mechanisms of inhibition, management and perspectives. Blood Coagul Fibrinolysis 2004; 15: 109-24.
5. Astermark J. Why do inhibitors develop? Principles of and factors influencing the risk for inhibitor development in haemophilia Haemophilia 2006; 12: 52-60.
6. Gill JC. The role of genetics in inhibitor formation. Thromb Hemost 1999; 82: 500-4.
7. Astermark J, Berntorp E, White GC, Kroner BL, the MIBS Study Group. The Malmo International Brother Study (MIBS): further support for genetic predisposition to inhibitor development. Haemophilia 2001; 7: 267-72.
8. Aledort L, Dimichele D. Inhibitors occur more frequently in African-American and Latino Haemophiliacs. Haemophilia 1998; 4: 68.
9. Soucie JM, Cianfrini C, Janco RL et al. Joint range-of-motion limitations among young males with hemophilia: prevalence and risk factors. Blood 2004; 103: 2467-73.
10. Gouw SC, van der Bom JG, van den Berg HM. Treatment-related risk factors of inhibitor development in previously untreated patients with hemophilia A: the CANAL cohort study. Blood 2007; 109: 4648-54.
11. Santagostino E, Mancuso ME, Rocino A et al. Environmental risk factors for inhibitor development in children with haemophilia A: a case control study. Brit J Haemat 2005; 130: 422-7.
12. Saunier JL, Irwin JA, Just RS, O'Callaghan J, Parsons TJ. Mitochondrial control region sequences from a U.S "Hispanic" population sample. Forens Sci Int: Genetics 2008; 2: e19-23.
13. Mattei J, Parnell LD, Lai C-Q et al. Disparities in allele frequencies and population differentiation for 101 disease-associated single nucleotide polymorphisms between Puerto Ricans and non-Hispanic whites. BMC Genetics 2009; 10: 45.
14. Campos-Sanchez R, Barrantes R, Silva S et al. Genetic structure analysis of three Hispanic populations from Costa Rica, Mexico, and the Southwestern United States using Y-chromosome STR markers and mtDNA sequences. Human Biol 2006; 78: 551-63.
15. Price AL, Patterson N, Yu F et al. A Genomewide admixture map for Latino populations. Am J Hum Genet 2007; 80: 1024-36.
16. Liu XQ, Paterson AD, John EM, Knight JA. The role of self-defined Race/Ethnicity in population structure control. Ann Hum Genet 2006; 70: 496-505.
17. Mantilla-Capacho JM, Beltrán-Miranda CP, Luna-Záizar H et al. Frequency of Intron 1 and 22 inversions of factor VIII Gene in Mexican patients with severe hemophilia A. Am J Hemat 2007; 82: 283-7.
18. Boekhorst J, Lari GR, D'Oiron R et al. Factor VIII genotype and inhibitor development in patients with haemophilia A: highest risk in patients with splice site mutations. Haemophilia 2008; 14: 729-35.
19. Oldenburg J, Pavlova A. Genetic risk factors for inhibitors to factors VIII and IX. Haemophilia 2006; 12: 15-22.
20. Ragni MV, Ojeifo O, Feng J et al. Risk factors for inhibitor formation in haemophilia: a prevalent case-control study. Haemophilia 2009; 15: 1074-82.
21. Soucie JM, Symons J, Evatt B et al. Home-based factor infusion therapy and hospitalization for bleeding complications among males with hemophilia. Haemophilia 2001; 7: 198-206.
22. Sharathkumar A, Lillicrap D, Blanchette VS et al. Intensive exposure to factor VIII is a risk factor for inhibitor development in mild hemophilia A. J Thromb Haemost 2003; 1: 1228-36.
23. Ranjit N, Diex-Roux AV, Shea S, Cushman M, Ni H, Seeman T. Socioeconomic position, race/ethnicity, and inflammation in the Multi-Ethnic Study of Atherosclerosis. Circulation 2007; 116: 2383-90.
24. White RH, Zhou H, Romano PS. Incidence of idiopathic deep venous thrombosis and secondary embolism among ethnic groups in California. Ann Intern Med 1998; 128: 737-40.
25. Astermark J, Oldenburg J, Pavlova A, Berntorp E, Lefvert AK, for the MIBS Study Group. Polymorphisms in the IL10 but not in the IL1beta and IL4 genes are associated with inhibitor development in patients with hemophilia A. Blood 2006; 107: 3167-72.
26. Astermark J, Oldenburg J, Carlson J et al. Polymorphisms in the TNFA gene and the risk of inhibitor development in patients with hemophilia A. Blood 2006; 108: 3739-45.
27. Pavlova A, Delev D, Lacroix-Desmazes S, Schwaab R, Mende M, Fimmers R, et al. Impact of polymorphisms of the MHC class II, IL-10, TNF-α and CTLA-4 genes on inhibitor development in severe hemophilia A. J Thromb Haemost 2009; 7: 2006-15.
28. Lozier JN, Menashe I, Goedert JJ, Rosenberg PS. A case-control study of candidate immunoregulartory genes reveals haplotypes that influence inhibitor risk in severe hemophilia A. [abstract] American Society of Hematology Meeting 2009. Abstract 218.
29. Viel KR, Ameri A, Abshire TC et al. Inhibitor of factor VIII in black patients with hemophilia. N Engl J Med 2009; 360: 1618-27.